Dexamethasone inhibits mucous glycoprotein secretion via a phospholipase A2-dependent mechanism in cultured chinchilla middle ear epithelial cells

Jizhen Lin, Steven K. Juhn, George L. Adams, G. Scott Giebink, Youngki Kim

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Inhibition or attenuation of mucous hypersecretion in middle ear epithelium is a key step toward resolution of mucoid otitis media. Mucous hypersecretion induced by platelet-activating factor (PAF) in cultured Chinchilla middle ear epithelial cells is dependent on arachidonic acid metabolites via PAF receptors, suggestive of the role of phospholipase A2 (PLA2) in mucous glycoprotein (MGP) secretion. In this study, dexamethasone added to cultured Chinchilla middle ear epithelial cells inhibited baseline and PAF-induced MGP secretion in a concentration-dependent manner. A definite time lag (16 h) was observed between administration of dexamethasone and MGP inhibition. This inhibition was reversed by the addition of exogenous PEA2 (the rate-limiting enzyme of arachidonic acid metabolism) and actinomycin D (an inhibitor of mRNA synthesis). This suggests that dexamethasone inhibits baseline and PAF-induced MGP secretion via a PLA2-dependent mechanism.

Original languageEnglish (US)
Pages (from-to)406-413
Number of pages8
JournalActa Oto-Laryngologica
Volume117
Issue number3
DOIs
StatePublished - 1997

Bibliographical note

Funding Information:
This study was supported by research grant number 5 PO1 DC 00133 from the National Institute on Deafness and Other Communication Disorders, National Institutes of Health.

Keywords

  • PLA middle ear epithelial cells in vitro
  • dexamethasone
  • mucous glycoprotein
  • platelet-activating factor

Fingerprint Dive into the research topics of 'Dexamethasone inhibits mucous glycoprotein secretion via a phospholipase A<sub>2</sub>-dependent mechanism in cultured chinchilla middle ear epithelial cells'. Together they form a unique fingerprint.

Cite this